IL27RA and neoplasm: Although not reaching statistical difference (P= 0.1224), a trend was observed the recipient mice seemed to also make a difference: wildtype recipient mice are more resistant to tumor formation than IL27RA−/− mice regardless whether they received bone marrow derived from wildtype or IL27RA−/− mice.